Compounds > 3,4-dihydroxyphenylglycol
Page last updated: 2024-08-26

3,4-dihydroxyphenylglycol and Cardiomyopathy, Hypertrophic Obstructive

3,4-dihydroxyphenylglycol has been researched along with Cardiomyopathy, Hypertrophic Obstructive in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brush, JE; Cannon, RO; Eisenhofer, G; Epstein, SE; Garty, M; Goldstein, DS; Maron, BJ; Panza, JA; Stull, R1

Other Studies

1 other study(ies) available for 3,4-dihydroxyphenylglycol and Cardiomyopathy, Hypertrophic Obstructive

ArticleYear
Cardiac norepinephrine kinetics in hypertrophic cardiomyopathy.
    Circulation, 1989, Volume: 79, Issue:4

    Topics: Adult; Cardiomyopathy, Hypertrophic; Female; Glycols; Humans; Isoproterenol; Male; Methoxyhydroxyphenylglycol; Middle Aged; Myocardium; Neurons; Norepinephrine; Sympathetic Nervous System; Tritium

1989